Covered recipient · General Payments record
ANDREW DOCKTER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$707.99
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $429.12 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $230.86 | 16 |
| Amgen Inc. | $76.75 | 5 |
| E.R. Squibb & Sons, L.L.C. | $38.11 | 2 |
| Actelion Pharmaceuticals US, Inc. | $26.62 | 1 |
| Astellas Pharma US Inc | $22.35 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.62 | 1 |
| Xeris Pharmaceuticals, Inc. | $13.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.39 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103648164 | CMS |
| ABBVIE INC. | $9.62 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103648166 | CMS |
| ABBVIE INC. | $10.12 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103648168 | CMS |
| ABBVIE INC. | $10.93 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103648170 | CMS |
| ABBVIE INC. | $19.47 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103648172 | CMS |
| ABBVIE INC. | $14.46 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103648174 | CMS |
| ABBVIE INC. | $25.05 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103648176 | CMS |
| ABBVIE INC. | $11.71 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103648178 | CMS |
| ABBVIE INC. | $25.88 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103648180 | CMS |
| ABBVIE INC. | $10.22 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103648182 | CMS |
| ABBVIE INC. | $10.77 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103648184 | CMS |
| ABBVIE INC. | $10.80 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103648186 | CMS |
| ABBVIE INC. | $10.92 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103648188 | CMS |
| ABBVIE INC. | $28.44 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103648190 | CMS |
| ABBVIE INC. | $13.34 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103648192 | CMS |
| ABBVIE INC. | $10.74 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103648194 | CMS |
| Actelion Pharmaceuticals US, Inc. | $26.62 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078898969 | CMS |
| Amgen Inc. | $15.08 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117240316 | CMS |
| Amgen Inc. | $16.37 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111564823 | CMS |
| Amgen Inc. | $15.43 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111564825 | CMS |
| Amgen Inc. | $14.09 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111564827 | CMS |
| Amgen Inc. | $15.78 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111564829 | CMS |
| Astellas Pharma US Inc | $22.35 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139395987 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.62 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117937333 | CMS |
| E.R. Squibb & Sons, L.L.C. | $18.67 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101839437 | CMS |
| E.R. Squibb & Sons, L.L.C. | $19.44 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101839466 | CMS |
| Xeris Pharmaceuticals, Inc. | $13.81 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144586628 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.